Fame and Mortality: Evidence from a Retrospective Analysis of Singers
November 26, 2025
Brand Name :
VESIcare
(United States) [Available] ,VESIcare LS
(United States) [Available]Synonyms :
Class :
Anticholinergic Agent and Urinary antispasmodics
Dosage Forms & Strengths Â
Tablet Â
5mg Â
10mg Â
Dosage Forms & Strengths Â
Oral suspension Â
1mg/mL  Â
may enhance the serum concentration of CYP3A4 inhibitors
it may increase the effect of anticholinergic agents 
it may increase the effect of anticholinergic agents 
it may increase the constipating effect of eluxadoline 
CYP3A strong enhancers of the small intestine may reduce the bioavailability of solifenacin 
the effect of solifenacin is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
Adverse drug reactions:  Â
Frequency Defined Â
>10% Â
Constipation Â
Dry mouth  Â
1-10% Â
Hypertension NOS  Â
Depression NOS  Â
Edema lower limb Â
Blurred vision  Â
Dizziness  Â
Upper abdominal pain Â
Dry eyes Â
Urinary tract infection Â
Dyspepsia Â
Nausea  Â
Influenza Â
Fatigue   Â
Urinary retentionÂ
Â
Pregnancy warnings:    Â
Pregnancy Category: N/AÂ
Breastfeeding warnings: Â
The release of the drug into the human breastmilk is unknownÂ
Pregnancy Categories:     Â
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.     Â
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women     Â
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women     Â
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits     Â
Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.     Â
Category N: There is no data available for the drug under this category
Patient Information Leaflet Â
Generic Name: solifenacinÂ
Pronunciation: SOE-li-FEN-a-sinÂ
Why do we use solifenacin?Â
solifenacin belongs to the class of Anticholinergics and acts as a Urinary antispasmodic used to treat overactive bladder in adults and Neurogenic Detrusor Overactivity in pediatricsÂ